Skip to main content
. 2022 Jun 1;8(22):eabm2510. doi: 10.1126/sciadv.abm2510

Table 1. Patient demographics.

HTN, hypertension; no PMHx, no previous medical history; Hep C, hepatitis C; BIPAP, bilevel positive airway pressure; PEG, percutaneous endoscopic gastrostomy; DLP, dyslipidemia; DM, diabetes mellitus; BPH, benign prostatic hyperplasia; Sx, symptoms; N/A, not applicable; SOC, standard of care.

Participant Sex Age Comorbidities Ethnicity Date of
Sx onset
Date of
diagnosis
Date of
admission
COVID-19
treatment
OS Days
hospitalized
Status at
discharge
Day 0 Day 3 Day 5 Day 8 Day 15
P1 F 46 HTN and anemia Asian 26 March
2020
8 April
2020
9 April
2020
SOC 7 7 6 7 4 7 Alive
P2 M 49 No PMHx Latin
American
16 April
2020
10 April
2020
16 April
2020
SOC 7 7 8 5 4 27 Alive
P3 F 31 HTN White N/A 11 April
2020
18 April
2020
Kaletra 7 9 8 DCD DCD 9 Deceased
P4 M 48 Hep C and renal
disease
Black 9 April
2020
16 April
2020
16 April
2020
SOC 7 9 9 8 9 35 Deceased
P5 M 41 Quadriplegic,
continuous BIPAP;
neurogenic
bladder; and PEG
White 7 April
2020
18 April
2020
18 April
2020
SOC 7 4 6 4 4 30 Alive
P6 F 78 Osteoporosis,
DLP,
osteoarthritis, and
right total hip
arthroplasty
White 30 April
2020
30 April
2020
7 May
2020
SOC 7 5 4 4 4 22 Alive
P7 M 92 Mild cognitive
impairment, HTN,
DM type 2, BPH,
and spinal
stenosis
White 17 May
2020
17 May
2020
18 May
2020
SOC 7 6 6 6 6 16 Deceased